Replies to post #164495 on Biotech Values

[DewDiligence]

The future of VX-135 depends on if 100mg in combination with other[s] works out.

VX-135 is all but dead at any dose, IMO. Why would anyone want to fool around testing combinations with a tainted drug when there are untainted options available?

ABBV showed that you don’t have to have a nuke in an HCV regimen for it to be effective.

[genisi]

The future of VX135 depends on if 100mg in combination with other works out.

Agree and note that the lower dose doesn't seem potent enough considering the high bar, so it may indicate it's a considerable if.